President of SNBB,Mr.Huang Liqi and BD Director of SNBB,Mr.John Zhang visited Esseti Farmacuetici s.r.l. of Italy January 10-11th,2011 at the invitation of Dr.Ventra,General Manager of Esseti,and Ms Valentina D'Acunzo,Far East Business Manager. After friendly and active negotiations,both companies reached consensus in certain areas for potential cooperation.
On November 2nd,2010,SNBB,together with Fudan Zhangjiang Bio-Pharmaceuticals., Ltd.,sponsored a hematological meeting in Shanghai.The academic topic of this meeting is "PEG Liposomal Doxorubicin in the treatment of hematological cancers".Speakers at the meeting are those most reknown and previliged clinical experts and academic professors who also have given their research-based evaluation of the positive therapeutic outcome of Libod®(PEG Liposomal Doxorubicin).About 60 delegates,most of whom are clinical directors from major hospitals in Shanghai,attended the meeting which was held at Pudong Fourpoints Sheraton Hotel in the afternoon.
SNBB's newly developed website has been launched since September.Now you can visit us at www.snbb.net which provides the most accurate and timely information concerning our company. The old website,www.shgjsw.com,can still be broused for some time but no more updating over its content.
In terms of business development,SNBB constantly updates its product portfolio in accordance with the ever-changing business environment of life sciences industry. We will be very willing to provide our product wish list to potential partners.
Tel: +86-21-65878357 
Fax: +86-21-65879702 
Email: info
Skype: snbbinfo 
